| Carols Personal Mastectomy | |
| 1490 E Foremaster Dr, Ste 320, St George, Utah 84790 | |
| (435) 688-0452 |
| Name | Carols Personal Mastectomy |
|---|---|
| Organization Name | Carol's Personal Mastectomy Boutique Of Southern Utah Llc |
| Location | 1490 E Foremaster Dr, Ste 320, St George, Utah 84790 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (435) 688-0452 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cipher Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.
Stockholm University researchers have found that the impact of climate change of disease incidence of tularemia could be statistically predicted. In high-latitude regions, where the disease was less common, global warming could lead to increasing number of cases of the disease they wrote.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
› Verified 6 days ago
| NPI Number | 1013014240 |
| Organization Name | CAROL'S PERSONAL MASTECTOMY BOUTIQUE OF SOUTHERN UTAH LLC |
| Doing Business As | CAROLS POST MASTECTOMY SPEC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1490 E Foremaster Dr Ste 310, St George, UT 84790 |
| Phone Number | 435-688-0452 |
News Archive
Cipher Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.
Stockholm University researchers have found that the impact of climate change of disease incidence of tularemia could be statistically predicted. In high-latitude regions, where the disease was less common, global warming could lead to increasing number of cases of the disease they wrote.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
› Verified 6 days ago
News Archive
Cipher Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.
Stockholm University researchers have found that the impact of climate change of disease incidence of tularemia could be statistically predicted. In high-latitude regions, where the disease was less common, global warming could lead to increasing number of cases of the disease they wrote.
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
› Verified 6 days ago
Petersen Medical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2019 E Riverside Dr, St George, Utah 84790 Phone: (435) 628-4949 | |
Alpine Home Medical Equipment Llc Type: DME Supplier - Oxygen Equipment & Supplies Location: 42 S River Rd, St George, Utah 84790 Phone: (435) 674-0080 | |
Carols Personal Mastectomy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1490 E Foremaster Dr, St George, Utah 84790 Phone: (435) 688-0452 | |
Central Utah Clinic P C Type: Medicare Supplier Location: 1490 E Foremaster Dr, St George, Utah 84790 Phone: (801) 429-8000 | |
Focus Eye Center Type: Medicare Supplier Location: 749 S River Rd, St George, Utah 84790 Phone: (435) 628-4464 |